Skip to main content

Table 3 Relationship of CDK5 expression with other clinicopathological variables in adenocarcinoma

From: Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China

Characteristic

Total number

No. patients, stratified by CDK5

Z

P value

Negative (29)

Positive (34)

Age

   

−2.316

0.021a

 ≤44

27

17 (63.0 %)

10 (37.0 %)

  

 >44

36

12 (33.3 %)

24 (66.7 %)

  

Lymph node metastasis

   

−1.269

0.205a

 Negative

18

6 (33.3 %)

12 (66.7 %)

  

 Positive

45

23 (51.1 %)

22 (48.9 %)

  

FIGO stage

   

−1.269

0.205a

 I–II

45

23 (51.1 %)

22 (48.9 %)

  

 III–IV

18

6 (33.3 %)

12 (66.7 %)

  

TNM stage

 I

43

23 (53.5 %)

20 (46.5 %)

2.983

0.084a

 II–IV

20

6 (30.0 %)

14 (70.0 %)

  

Pathological stage

   

5.455

0.065b

 I

10

6 (60.0 %)

4 (40.0 %)

  

 II

38

20 (52.6 %)

18 (47.4 %)

  

 III

15

3 (20.0 %)

12 (80.0 %)

  
  1. FIGO International Federation of Gynecology and Obstetrics, TNM tumor node metastasis
  2. aTwo independent-samples Chi square test was performed
  3. bKruskal–Wallis H test was performed